RE:Chris Parry .....Did people read the release? It wasn't good but unless I'm wrong Telesta is still a well funded, partnered, peer reviewed, documented phase 3 company. Sure, as of yesterday's close, it had the valuation of a pre clinical operation, but now trading below cash? MCNA is suddenly a worthless property? That makes no sense. Whatever the shortcomings of the first trial were an awful lot of people in the encompassing urology field saw an awful lot of life preserving value. The question is whether or not you trust the judgment of those who oversaw two recent failures to guide it forward. I'm hoping that they have enough credible guidance around them to see it through.